Cargando…

Investigating hypothiocyanite against SARS-CoV-2

Detalles Bibliográficos
Autor principal:	Cegolon, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier GmbH. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135769/ https://www.ncbi.nlm.nih.gov/pubmed/32305009 http://dx.doi.org/10.1016/j.ijheh.2020.113520

Ejemplares similares

Hypothiocyanite and Hypothiocyanite/Lactoferrin Mixture Exhibit Virucidal Activity In Vitro against SARS-CoV-2
por: Cegolon, Luca, et al.
Publicado: (2021)

Microbicidal Activity of Hypothiocyanite against Pneumococcus
por: Yassine, Edriss, et al.
Publicado: (2021)

Enhancing hypothiocyanite production by lactoperoxidase – mechanism and chemical properties of promotors
por: Gau, Jana, et al.
Publicado: (2015)

Oxidative killing of encapsulated and nonencapsulated Streptococcus pneumoniae by lactoperoxidase-generated hypothiocyanite
por: Gingerich, Aaron D., et al.
Publicado: (2020)

Escherichia coli RclA is a highly active hypothiocyanite reductase
por: Meredith, Julia D., et al.
Publicado: (2022)

The Significance of Hypothiocyanite Production via the Pendrin/DUOX/Peroxidase Pathway in the Pathogenesis of Asthma
por: Izuhara, Kenji, et al.
Publicado: (2017)

Supporting the Aspecific Physiological Defenses of Upper Airways against Emerging SARS-CoV-2 Variants
por: Cegolon, Luca, et al.
Publicado: (2023)

Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system
por: Patel, Urmi, et al.
Publicado: (2018)

The Hypothiocyanite and Amantadine Combination Treatment Prevents Lethal Influenza A Virus Infection in Mice
por: Ashtiwi, Nuha Milad, et al.
Publicado: (2022)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020–31 January 2023
por: Cegolon, Luca, et al.
Publicado: (2023)

Molecular modelling investigation for drugs and nutraceuticals against protease of SARS-CoV-2
por: Kodchakorn, Kanchanok, et al.
Publicado: (2020)

Acridone Alkaloids: In-Silico Investigation Against SARS-CoV-2 Main Protease
por: Oderinlo, Ogunyemi Olajide, et al.
Publicado: (2022)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2020)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2021)

Investigating Neurological Manifestations of SARS-CoV-2
por: Mozafar, Maryam, et al.
Publicado: (2021)

Computational and comparative investigation of hydrophobic profile of spike protein of SARS-CoV-2 and SARS-CoV
por: Shekhawat, Uma, et al.
Publicado: (2022)

Culinary spice bioactives as potential therapeutics against SARS-CoV-2: Computational investigation
por: Natesh, Jagadish, et al.
Publicado: (2021)

A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2
por: Jo, Seri, et al.
Publicado: (2021)

Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy)
por: Basso, Paolo, et al.
Publicado: (2022)

Investigation of Animal Reservoir(s) of SARS-CoV
por: Hu, Zhihong, et al.
Publicado: (2008)

Investigation of SARS CoV-2 virus in environmental surface
por: Dargahi, Abdollah, et al.
Publicado: (2021)

Updated Approaches against SARS-CoV-2
por: Li, Haiou, et al.
Publicado: (2020)

Music of Microbiota Against SARS CoV-2
por: Belojevic, Goran, et al.
Publicado: (2019)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants
por: Qu, Yuanyuan, et al.
Publicado: (2021)

Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2
por: Mufamadi, Maluta Steven, et al.
Publicado: (2023)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation
por: El-hoshoudy, A.N.
Publicado: (2020)

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
por: Lyke, Kirsten E., et al.
Publicado: (2023)

Investigative study into whether an insect repellent has virucidal activity against SARS-CoV-2
por: Smither, Sophie J., et al.
Publicado: (2021)

Current HLA Investigations on SARS-CoV-2 and Perspectives
por: Douillard, Venceslas, et al.
Publicado: (2021)

Structural investigations of proteins encoded by SARS‐CoV‐2
por: Wlodawer, Alexander
Publicado: (2022)

Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV
por: Scroggs, Stacey L. P., et al.
Publicado: (2020)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
por: Trigueiro-Louro, João, et al.
Publicado: (2020)

Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial
por: Cegolon, Luca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ur3aqs7f53rcej8tetl455poqg